Serum Life Sciences Ltd, a unit of India-based SII, will pick up a 3.9% stake in Oxford Biomedica as part of the deal. Oxford Biomedica, sp...

These are some of the sectors and stocks in traders’ sights for their roles in the global vaccine rollout.